V.Vande WoudeG
The BC application and its combination with PGPR resulted in the high values of phenols content (on average 6.70 and 7.74 mg g 1 D.W
Users who succeed with IGF-1 LR3 are those willing to manage glucose proactively, rotate injection sites obsessively, and accept that half the weight gained in the first two weeks will be water
Pvloiu RD, Shaat F, Neagu G, Deaconu M, Bubueanu C, Albulescu A, et al
XJZ regulated all 15 differential metabolic pathways
Semaglutide 2.4mg (GLP-1 Agonist): Proven GLP-1 effects (appetite suppression, gastric emptying) Already FDA-approved as Wegovy Established safety profile Cagrilintide 2.4mg (Amylin Analog): Mimics amylin, a hormone co-secreted with insulin Slows gastric emptying through different pathway than GLP-1 Reduces appetite through hindbrain (not hypothalamus) Improves postprandial glucose The Advantage: Leverages proven semaglutide efficacy and safety, adds complementary amylin effects
